Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
GLP-1 weight-loss medications linked to improved cancer survival in certain patients
GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San Diego researchers found in a 6,800-patient study. Read More
Weight loss drugs Ozempic and Wegovy may cut cancer death risk by over half? New study reveals shocking truth
When we talk about medications like Ozempic and Wegovy, the conversation often centres on weight loss, blood sugar control and body-image transformations. However, a powerful new study suggests that ... Read More
Popular weight-loss drugs could take the edge off your alcohol buzz, study finds
Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ... Read More
Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the ... Read More
GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ... Read More
Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash
Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ... Read More
Eli Lilly partners with Walmart to sell weight loss drug directly to patients nationwide
Patients will be able to access Eli Lilly's weight loss drug Zepbound at Walmart pharmacies nationwide through its direct-to-consumer program as soon as next month. The partnership between Eli Lilly ... Read More
A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk
A new University College London study featuring 17,604 participants age 45 and up discovered that semaglutide -- a GLP-1 agonist found in weight-loss drugs like Ozempic and Wegovy -- decreases the ... Read More
White House Deal Lowers Prices of Weight-Loss Drugs
The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus